Latest News and Press Releases
Want to stay updated on the latest news?
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Verve Therapeutics, Inc....
-
Robbins LLP is Investigating Allegations that Verve Therapeutics, Inc. (VERV) Misled Investors Regarding its Clinical Trial
-
Robbins LLP is Investigating Allegations that Verve Therapeutics, Inc. (VERV) Misled Investors Regarding its Clinical Trial
-
SAN DIEGO, Sept. 09, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of purchasers or acquirers of publicly traded Verve Therapeutics, Inc. (NASDAQ: VERV) (“Verve” or the...
-
Robbins LLP is Investigating Allegations that Verve Therapeutics, Inc. (VERV) Misled Investors Regarding its Clinical Trial
-
Robbins LLP is Investigating Allegations that Verve Therapeutics, Inc. (VERV) Misled Investors Regarding its Clinical Trial
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Verve Therapeutics, Inc....
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Verve Therapeutics, Inc....